RxDoctor Payments Data

Abdelmoniem Moustafa, MD

Internal Medicine · Providence, RINPI 1477937696

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (51.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medtronic at 58.7% of the total. Reporting peaked in 2024 at $11,463 and has fallen 87.8% since, to $1,398 in 2025. Among internal medicine clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,383in general payments, 2019–2025

Across 63 payments — averaging $212.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Medical Device Business Services, Inc.$2K
  • Boston Scientific$1K
  • Biotronik Inc.$1K
  • Philips North America LLC$993
  • Abbott$169
  • plus $433 from 8 others

What the payments were for

  • Grants$6,84851%
  • Travel & lodging$4,62735%
  • Food & beverage$1,57812%
  • Education$3302%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,383 in reported general payments places this provider in the 95th percentile of 808 internal medicine providers in Rhode Island.

See all internal medicine providers in Rhode Island

Medicare billing

Part B allowed, 2024
$1,469
Medicare patients
11
Services billed
17

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium11$68

Paid to pharmacies, not to this prescriber.

Other internal medicine in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →